Jazz Pharmaceuticals Announces Second Quarter 2022 Financial Results and Affirms 2022 Financial Guidance
Go back to Jazz Pharmaceuticals Announces Second Quarter 2022 Financial Results and Affirms 2022 Financial Guidance| JAZZ PHARMACEUTICAL (NASDAQ: JAZZ) | Delayed: 240.74 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $240.74 | 52 Week High | $160.00 | |||
| Open | $240.74 | 52 Week Low | $95.80 | |||
| Day High | $240.74 | P/E | 44.75 | |||
| Day Low | $240.74 | EPS | $5.38 | |||
| Volume | 2,644 | |||||
